StreetInsider.com News Articles

Richard Lowenthal resigns from ARS Pharmaceuticals board

Fri, 17 Jul 2026 16:05:16 -0400

Richard Lowenthal resigned from the board of directors of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) on July 15, 2026, effective immediately.

According to a company statement, Lowenthal's resignation was a condition of his right to receive severance compensation under the terms of his employment agreement and the company's Change in Control and Severance Benefit Plan. The arrangement was previously described in the company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 29, 2026.

Also on July 15, 2026, Sarina Tanimoto, M.D., the company's Chief Medical Officer, ceased employment with ARS Pharmaceuticals under conditions constituting a termination without cause.

Richard Lowenthal resigns from ARS Pharmaceuticals board

Fri, 17 Jul 2026 16:05:16 -0400

Richard Lowenthal resigned from the board of directors of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) on July 15, 2026, effective immediately.

Also on July 15, 2026, Sarina Tanimoto, M.D., the company's Chief Medical Officer, ceased employment with ARS Pharmaceuticals under conditions constituting a termination without cause.

Form 8-K ARS Pharmaceuticals, For: Jul 15

Fri, 17 Jul 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260717/26784284.html

Form 8-K ARS Pharmaceuticals, For: Jul 15

Fri, 17 Jul 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260717/26784284.html

Form SCHEDULE 13G/A ARS Pharmaceuticals, Filed by: MILLENNIUM MANAGEMENT LLC

Tue, 14 Jul 2026 17:47:00 -0400

si-local-file:///var/storage/secattach/20260714/26769231.html

Form SCHEDULE 13G/A ARS Pharmaceuticals, Filed by: MILLENNIUM MANAGEMENT LLC

Tue, 14 Jul 2026 17:47:00 -0400

si-local-file:///var/storage/secattach/20260714/26769231.html

Form 8-K ARS Pharmaceuticals, For: Jul 06

Tue, 07 Jul 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260707/26742307.html

Form 8-K ARS Pharmaceuticals, For: Jul 06

Tue, 07 Jul 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260707/26742307.html

ARS Pharmaceuticals names Donn Casale as CEO, replacing co-founder

Tue, 07 Jul 2026 16:30:35 -0400

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) announced that co-founder and Chief Executive Officer Richard Lowenthal departed the company effective July 6, 2026, after more than a decade leading the San Diego-based biopharmaceutical firm since its founding in 2015.

The company's board appointed Donn Casale, who had been serving as President, as CEO and Director effective July 7, 2026.

Casale brings more than 25 years of biopharmaceutical commercial and business leadership. Before joining ARS Pharmaceuticals, he served as Chief Commercial Officer at Dynavax Technologies, where he helped scale the hepatitis B vaccine HEPLISAV-B from launch to more than $300 million in annualized revenue and

ARS Pharmaceuticals names Donn Casale as CEO, replacing co-founder

Tue, 07 Jul 2026 16:30:35 -0400

The company's board appointed Donn Casale, who had been serving as President, as CEO and Director effective July 7, 2026.

ARS Pharmaceuticals Announces CEO Succession

Tue, 07 Jul 2026 16:30:00 -0400

Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company

Donn Casale, President, Appointed Chief Executive Officer and Director

SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect against allergic reactions that could lead to anaphylaxis, today announced a CEO succession, in which co-founder and CEO Richard Lowenthal will no longer serve as an employee and officer of the company effective July 6, 2026. The Board has appointed Donn

ARS Pharmaceuticals Announces CEO Succession

Tue, 07 Jul 2026 16:30:00 -0400

Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company

Donn Casale, President, Appointed Chief Executive Officer and Director

Form 4 ARS Pharmaceuticals, For: Jul 01 Filed by: Casale Donn

Thu, 02 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260702/26728403.html

Form 4 ARS Pharmaceuticals, For: Jul 01 Filed by: Casale Donn

Thu, 02 Jul 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260702/26728403.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shah Rajeev M.

Fri, 26 Jun 2026 16:52:00 -0400

si-local-file:///var/storage/secattach/20260626/26699620.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shah Rajeev M.

Fri, 26 Jun 2026 16:52:00 -0400

si-local-file:///var/storage/secattach/20260626/26699620.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Dadoo Rajeev

Fri, 26 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260626/26699122.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Dadoo Rajeev

Fri, 26 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260626/26699122.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Kelly Michael

Fri, 26 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260626/26698888.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Kelly Michael

Fri, 26 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260626/26698888.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shah Pratik

Fri, 26 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260626/26698890.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Shah Pratik

Fri, 26 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260626/26698890.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: SAUNDERS BRENT L

Fri, 26 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260626/26698878.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: SAUNDERS BRENT L

Fri, 26 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260626/26698878.html

Form 4 ARS Pharmaceuticals, For: Jun 24 Filed by: Thompson Peter A.

Fri, 26 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260626/26698879.html